These results indicate the abnormal elevation of H3K4me3 depends on Skp2, at least in Pten/Trp53 null background, which implicating that SKP2 plays an essential role in dysregulation of H3K4me3 for the development and progression of cancers. Here, SKP2 is linked to cancer.